Chemistry:AZD3676

From HandWiki

AZD3676 is a drug which acts as a potent and selective antagonist for the 5-HT1A receptor and 5-HT1B receptors, with some selectivity for 5-HT1A. It has been researched for potential applications in the treatment of cognitive impairment in Alzheimer's disease.[1][2]

See also

References

  1. ↑ Malmstrom JS, Andersson JS, Nordvall GS, Gyback HS, Terp GS, Weigelt TS, Linde CE, Johansson AS, "2-carboxamide-7-piperazinyl-benzofuran derivatives", US patent 8859534, published 2013-02-04, issued 2014-10-14, assigned to Acturum Life Science AB [Se]and Astrazeneca AB [Se]
  2. ↑ "Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676". The Journal of Pharmacology and Experimental Therapeutics 358 (3): 464–471. September 2016. doi:10.1124/jpet.116.234146. PMID 27402278.